3,4-dihydroxyphenylacetic acid has been researched along with isotretinoin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Ali, SF; Cisneros, FJ; Ferguson, SA; Gough, BJ | 1 |
3 other study(ies) available for 3,4-dihydroxyphenylacetic acid and isotretinoin
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Four weeks of oral isotretinoin treatment causes few signs of general toxicity in male and female Sprague-Dawley rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Oral; Animals; Anticarcinogenic Agents; Brain; Dermatologic Agents; Dopamine; Dose-Response Relationship, Drug; Eating; Estrous Cycle; Female; Isotretinoin; Kidney; Male; Organ Size; Rats; Rats, Sprague-Dawley; Serotonin; Spleen; Testis; Toxicity Tests | 2005 |